153 related articles for article (PubMed ID: 18326910)
21. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type.
Wu X; Li P; Zhao J; Yang X; Wang F; Yang YQ; Fang F; Xu Y; Zhang H; Wang WY; Yi C
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):619-25. PubMed ID: 18790372
[TBL] [Abstract][Full Text] [Related]
22. High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission.
Papajik T; Raida L; Faber E; Vondrakova J; Prochazka V; Kubova Z; Skoumalova I; Jarosova M; M LK; Paucek B; Myslivecek M; Neoral C; Oral I; Jarkovsky J; Dusek L; Indrak K
Neoplasma; 2008; 55(3):215-21. PubMed ID: 18348654
[TBL] [Abstract][Full Text] [Related]
23. [Primary non-Hodgkin lymphoma in the female genital system: a report of 28 cases].
Hu Y; Feng FY; Zhang P; Zhou LQ; Zhang WH; Wang QL
Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):486-9. PubMed ID: 14575576
[TBL] [Abstract][Full Text] [Related]
24. Hematopoietic stem cell transplantation in the treatment of peripheral T-cell lymphomas.
Majhail NS; Burns LJ
Curr Hematol Rep; 2005 Jul; 4(4):252-9. PubMed ID: 16009039
[TBL] [Abstract][Full Text] [Related]
25. Primary localized stages I and II non-Hodgkin's lymphoma of the nasopharynx: a retrospective 17-year single institutional experience.
Mohammadianpanah M; Ahmadloo N; Mozaffari MA; Mosleh-Shirazi MA; Omidvari S; Mosalaei A
Ann Hematol; 2009 May; 88(5):441-7. PubMed ID: 18931844
[TBL] [Abstract][Full Text] [Related]
26. Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets.
Rodríguez J; Gutiérrez A; Martínez-Delgado B; Perez-Manga G
Crit Rev Oncol Hematol; 2009 Sep; 71(3):181-98. PubMed ID: 19056295
[TBL] [Abstract][Full Text] [Related]
27. Peripheral T cell lymphoma: The Sheffield Lymphoma Group experience (1977-2001).
Musson R; Radstone CR; Horsman JM; Hancock H; Goepel JR; Hancock BW;
Int J Oncol; 2003 Jun; 22(6):1363-8. PubMed ID: 12739006
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation.
Kyriakou C; Canals C; Finke J; Kobbe G; Harousseau JL; Kolb HJ; Novitzky N; Goldstone AH; Sureda A; Schmitz N
J Clin Oncol; 2009 Aug; 27(24):3951-8. PubMed ID: 19620487
[TBL] [Abstract][Full Text] [Related]
29. [International prognostic index in diffuse B large cell lymphosarcoma].
Magomedova AU; Vorob'ev AI
Ter Arkh; 2008; 80(3):71-6. PubMed ID: 18441690
[TBL] [Abstract][Full Text] [Related]
30. Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma.
Porrata LF; Ristow K; Habermann TM; Witzig TE; Inwards DJ; Markovic SN
Am J Hematol; 2009 Feb; 84(2):93-7. PubMed ID: 19123458
[TBL] [Abstract][Full Text] [Related]
31. [Retrospective analysis of 54 patients with high risk aggressive T-cell non-Hodgkin lymphomas].
Yuan XL; Li QC; Zou DH; Zhao YZ; Wang YF; Wang Y; Zhang JW; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):454-7. PubMed ID: 18072627
[TBL] [Abstract][Full Text] [Related]
32. MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma.
De Sanctis V; Finolezzi E; Osti MF; Grapulin L; Alfò M; Pescarmona E; Berardi F; Natalino F; Moleti ML; Di Rocco A; Enrici RM; Foà R; Martelli M
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1154-60. PubMed ID: 18472357
[TBL] [Abstract][Full Text] [Related]
33. Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire.
Le Gouill S; Milpied N; Buzyn A; De Latour RP; Vernant JP; Mohty M; Moles MP; Bouabdallah K; Bulabois CE; Dupuis J; Rio B; Gratecos N; Yakoub-Agha I; Attal M; Tournilhac O; Decaudin D; Bourhis JH; Blaise D; Volteau C; Michallet M;
J Clin Oncol; 2008 May; 26(14):2264-71. PubMed ID: 18390969
[TBL] [Abstract][Full Text] [Related]
34. Clinical and pathological diagnosis of peripheral T-cell lymphoma and emerging treatment options: A case-based discussion.
Said J; Pinter-Brown L
Clin Adv Hematol Oncol; 2009 Nov; 7(11):S1, S4-13; quiz S15. PubMed ID: 20095101
[TBL] [Abstract][Full Text] [Related]
35. Predictive and discriminating three-risk-group prognostic scoring system for staging Hodgkin lymphomas.
Maucort-Boulch D; Djeridane M; Roy P; Riche B; Colonna P; Andrieu JM
Cancer; 2007 Jan; 109(2):256-64. PubMed ID: 17154164
[TBL] [Abstract][Full Text] [Related]
36. Nongastric marginal zone B-cell lymphoma: a prognostic model from a retrospective multicenter study.
Oh SY; Kwon HC; Kim WS; Park YH; Kim K; Kim HJ; Kwon JM; Lee J; Ko YH; Ahn YC; Oh SJ; Lee SI; Bang SM; Kim JH; Park J; Ryoo BY; Lee SS; Kim HY; Park K; Kim HJ
Cancer Lett; 2007 Dec; 258(1):90-7. PubMed ID: 17936499
[TBL] [Abstract][Full Text] [Related]
37. [Clinicopathological analysis of patients with angioimmunoblastic T-cell lymphoma (AILT)].
Saito A; Miyazawa Y; Isoda A; Hatsumi N; Matsumoto M; Kojima M; Sawamura M
Rinsho Ketsueki; 2008 Feb; 49(2):82-8. PubMed ID: 18341037
[TBL] [Abstract][Full Text] [Related]
38. Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan.
Shimada K; Matsue K; Yamamoto K; Murase T; Ichikawa N; Okamoto M; Niitsu N; Kosugi H; Tsukamoto N; Miwa H; Asaoku H; Kikuchi A; Matsumoto M; Saburi Y; Masaki Y; Yamaguchi M; Nakamura S; Naoe T; Kinoshita T
J Clin Oncol; 2008 Jul; 26(19):3189-95. PubMed ID: 18506023
[TBL] [Abstract][Full Text] [Related]
39. Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi survey.
Tarella C; Zanni M; Magni M; Benedetti F; Patti C; Barbui T; Pileri A; Boccadoro M; Ciceri F; Gallamini A; Cortelazzo S; Majolino I; Mirto S; Corradini P; Passera R; Pizzolo G; Gianni AM; Rambaldi A
J Clin Oncol; 2008 Jul; 26(19):3166-75. PubMed ID: 18490650
[TBL] [Abstract][Full Text] [Related]
40. Reassessment of the prognostic factors of international prognostic index (IPI) in the patients with diffuse large B-cell lymphoma in an era of R-CHOP in Chinese population.
Yang S; Yu Y; Jun-Min L; Jian-Qing M; Qiu-Sheng C; Yu C; Wei-Li Z; Jian-Hua Y; Hui-Jin Z; Yan W; Li W; Shu C; Zhi-Xiang S
Ann Hematol; 2009 Sep; 88(9):863-9. PubMed ID: 19205655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
